2. Peptides
  3. Peptide and Derivatives
  4. Others
  5. Drug Derivatives

Drug Derivatives

Custom Peptide Synthesis

Drug-derived peptides are peptide fragments or intermediates derived from active pharmaceutical molecules or candidate compounds. They are widely utilized in studies of drug structure.

Drug Derivatives (56):

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-160429
    PSAR18-COOH 2313534-26-6 99.50%
    PSAR18-COOH is a derivative of PSAR extracted from patent WO2009064913A1. PSAR is a highly hydrophilic, biodegradable, non-immunogenic and water-soluble polymer that has been employed in several delivery systems for drugs or diagnostics.
    PSAR18-COOH
  • HY-Z11724
    Semaglutide Main Chain (9-37) 1169630-82-3 99.63%
    Semaglutide Main Chain (9-37) is a peptide starting material in the synthesis of semaglutide (HY-114118).
    Semaglutide Main Chain (9-37)
  • HY-P1505A
    C3a (70-77) TFA 99.79%
    C3a (70-77) TFA (Complement 3a (70-77) TFA) is an octapeptide corresponding to the COOH terminus of C3a, exhibits the specificity and 1 to 2% biologic activities of C3a.
    C3a (70-77) TFA
  • HY-P4917A
    Somatostatin-14 (reduced) TFA 99.18%
    Somatostatin-14 (reduced) (SST 14) (TFA) is a peptide that can be discovered through peptide screening. Peptide screening is a research tool primarily used for identifying active peptides through immunoassays. It can be employed in protein interactions, functional analysis, antigen epitope screening, and is particularly useful in the research and development of active molecules.
    Somatostatin-14 (reduced) TFA
  • HY-P3146A
    FTISADTSK acetate 99.66%
    FTISADTSK acetate is an endogenous stable signature peptide from Trastuzumab monitored by selected reaction monitoring (SRM).
    FTISADTSK acetate
  • HY-P11363
    (Des-Asp1,Ile8)-Angiotensin II 52498-25-6 98.93%
    (Des-Asp1,Ile8)-Angiotensin II is a peptide related to angiotensin II. (Des-Asp1,Ile8)-Angiotensin II can be used for studying the interaction between angiotensin II and its receptors.
    (Des-Asp1,Ile8)-Angiotensin II
  • HY-P10474
    RYTVELA 1200829-06-6 98.89%
    RYTVELA is a deriviative of the peptide antagonist of interleukin-1 receptor 1 (IL-1R1) d-(RYTVELA) (HY-P10353) that contains all L-amino acids.
    RYTVELA
  • HY-P3147A
    IYPTNGYTR acetate 99.02%
    IYPTNGYTR acetate, a deamidation-sensitive signature peptide, is a deamidation product of Trastuzumab. IYPTNGYTR acetate can be used to monitor in vivo Trastuzumab metabolism.
    IYPTNGYTR acetate
  • HY-P1355A
    Cyclosporin A-Derivative 1 Free base 286852-20-8 98.20%
    Cyclosporin A-Derivative 1 (Free base) is a crystalline intermediate derived from the opening of cyclosporin A extracted from patent WO 2013167703 A1. Cyclosporin A is an immunosuppressive agent which can bind to the cyclophilin and inhibit calcineurin.
    Cyclosporin A-Derivative 1 Free base
  • HY-W1116287
    N-Acetyl-Sar24 2313534-28-8
    N-Acetyl-Sar24 is an acetylated derivative of Sarcosine (HY-101037).
    N-Acetyl-Sar24
  • HY-P1460
    His-[D-2-ME-Trp]-Ala 3026595-80-9 99.92%
    His-[D-2-ME-Trp]-Ala is a fragment of the growth hormone hexarelin.
    His-[D-2-ME-Trp]-Ala
  • HY-P3203A
    DSTYSLSSTLTLSK TFA 98.44%
    DSTYSLSSTLTLSK TFA is a generic human peptide and can be used for infliximab quantitative detection. Infliximab (Avakine) is a chimeric monoclonal IgG1 antibody that specifically binds to TNF-α.
    DSTYSLSSTLTLSK TFA
  • HY-P3207A
    DLPLTFGGGTK TFA 98.11%
    DLPLTFGGGTK (TFA) is a surrogate peptide for pembrolizumab identification.
    DLPLTFGGGTK TFA
  • HY-P3149B
    LEESGGGLVQPGGSMK acetate 99.01%
    LEESGGGLVQPGGSMK acetate, a proteolysis peptide, is a component of Infliximab. LEESGGGLVQPGGSMK acetate can be used for quantitative analysis of Infliximab. Infliximab is a chimeric monoclonal IgG1 antibody that specifically binds to TNF-α.
    LEESGGGLVQPGGSMK acetate
  • HY-P1574A
    [Arg8]-Vasotocin TFA 98.41%
    [Arg8]-Vasotocin (TFA) is a vertebrate neurohypophyseal peptide of the vasopressin/oxytocin hormone family.
    [Arg8]-Vasotocin TFA
  • HY-P1358
    Alisporivir intermediate-1 882506-05-0 98.06%
    Alisporivir intermediate-1 is an intermediate in the synthesis of Alisporivir. Alisporivir is used for the treatment of inflammatory and viral diseases.
    Alisporivir intermediate-1
  • HY-P1574
    [Arg8]-Vasotocin 113-80-4
    [Arg8]-Vasotocin is a vertebrate neurohypophyseal peptide of the vasopressin/oxytocin hormone family.
    [Arg8]-Vasotocin
  • HY-P1505
    C3a (70-77) 63555-63-5
    C3a (70-77) is an octapeptide corresponding to the COOH terminus of C3a, exhibits the specificity and 1 to 2% biologic activities of C3a.
    C3a (70-77)
  • HY-P1227
    SDV-Exendin-3/4
    SDV-Exendin-3/4 is a 32-amino acid peptide.
    SDV-Exendin-3/4
  • HY-P1223
    Exendin-3/4 (59-86) 1263874-37-8 98.19%
    Exendin-3/4 (59-86) is a Exendin-4 peptide derivative.
    Exendin-3/4 (59-86)